Submitted by Anonymous (not verified) on 24 August 2023 - 14:10
Opinion/decision on a Paediatric investigation plan (PIP): RoActemra,tocilizumab, decision type: , therapeutic area: , PIP number: P/0354/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): RoActemra,tocilizumab, decision type: , therapeutic area: , PIP number: P/0354/2022